Citius Oncology, Inc. CTOR Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s income tax?
- Citius Oncology, Inc. (CTOR) reported income tax of -$231.21K in Q1 2026.
- How has Citius Oncology, Inc.'s income tax changed year-over-year?
- Citius Oncology, Inc.'s income tax decreased by 187.5% year-over-year, from $264.24K to -$231.21K.
- What is the long-term trend for Citius Oncology, Inc.'s income tax?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s income tax has grown at a 35.5% compound annual growth rate (CAGR), from $576K to $1.06M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.